Campaigns

Ongoing, global campaign working to accelerate equitable access to affordable, generic hepatitis C treatments. More

• About the Campaign
• Gilead’s License on Hepatitis C Drugs, Sofosbuvir and Ledipasvir: a Fool’s Bargain
• Doctors of the World Opposes the Patent on Sofosbuvir
• APN+ Joins MTAAG+ in Congratulating Malaysia on Sofosbuvir Compulsory License
• Hepatitis C Cure, Sofosbuvir, Turns 5 Years Old: The Vast Majority of People Still Nave Not Been Treated
• Activists Demand Affordable Hepatitis C Treatment
• First Hepatitis C Treatment Developed Through South-South Cooperation Registered in Malaysia
• Gilead’s Claim That Generic Purchase of Sofosbuvir Would Lead to Patent Infringement in Brazil Dismissed
• Sofosbuvir Case in Brazil
• LAT CAB Calls on AbbVie, Licensed Generic Manufacturers of G/P, and the Medicines Patent Pool to Fulfill their Commitment to Make Generic HCV Treatment Widely Available
• Treatment for Hepatitis C: The Patent System is Standing in the Way of Access to Medicine

Ongoing, global campaign focusing on where the registration of diagnostics and direct-acting antivirals has stalled as well as the slow treatment uptake in low- and middle-income countries. More

• About the Campaign
• Have a Heart, Save My Liver!: Where Are My Diagnostics?
• Who Has Access to Hepatitis C Testing? Liberate Our Diagnostics!
• Access to Hepatitis C Treatment and Care Among People Who Inject Drugs: Failing People Most Disproportionately Affected
• Have a Heart, Save My Liver! Where is the Cure Registered?
• Have a Heart, Save My Liver! Which Countries Restrict Treatment?
• Have a Heart, Save My Liver! Why Hepatitis C Virus Care Remains Inaccessible

Ongoing, global campaign targeting bilateral and multilateral donors to step up funding for viral hepatitis and harm reduction to curb the epidemics. More

• About the Campaign
• We Need a Comprehensive Hepatitis C Package of Services for People Who Use and Inject Drugs!
• PEPFAR Watch!—Resource Tools for Funding Advocacy
• Advocates Demand Continuous Catalytic Investment Towards Viral Hepatitis Elimination
• Achieving Hepatitis C Elimination in Pakistan
• INPUD Summary Report: WHO Key Populations’ Values & Preferences for HIV, Hepatitis and STIs Services
• Promoting Interventions for Viral Hepatitis and Harm Reduction in PEPFAR COPs - Webinar Materials in English, Portuguese and French
• Fully Fund the Global Fund: Harm Reduction Brief
• The Opportunity to Eliminate Hepatitis C through Alternative Financing Mechanisms

Ongoing, global campaign demanding universal, equitable access to HCV cure for everyone who needs it. More

• About the Campaign
• Have a Heart, Save My Liver! Why Hepatitis C Virus Care Remains Inaccessible
• Beyond Intellectual Property: Why Is Generic Treatment for HCV Still So Hard to Get

We need a comprehensive hepatitis C package of services for people who use and inject drugs! More

• We Need a Comprehensive Hepatitis C Package of Services for People Who Use and Inject Drugs!
• Who Counts in Our National Hepatitis Plans?
• Intervention Toolkit for Hepatitis C
• Recommended Package of Interventions for HIV, Viral Hepatitis and STI Prevention, Diagnosis, Treatment and Care for People who Inject Drugs